Instil Bio Inc (TIL)
27.85
-0.93
(-3.23%)
USD |
NASDAQ |
Nov 04, 16:00
27.85
0.00 (0.00%)
After-Hours: 20:00
Instil Bio Enterprise Value: 120.50M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 120.50M |
| October 31, 2024 | 139.95M |
| October 30, 2024 | 156.27M |
| October 29, 2024 | 157.12M |
| October 28, 2024 | 162.84M |
| October 25, 2024 | 135.33M |
| October 24, 2024 | 134.16M |
| October 23, 2024 | 140.21M |
| October 22, 2024 | 151.72M |
| October 21, 2024 | 160.31M |
| October 18, 2024 | 176.89M |
| October 17, 2024 | 189.96M |
| October 16, 2024 | 199.98M |
| October 15, 2024 | 195.30M |
| October 14, 2024 | 216.76M |
| October 11, 2024 | 206.94M |
| October 10, 2024 | 177.15M |
| October 09, 2024 | 184.76M |
| October 08, 2024 | 164.86M |
| October 07, 2024 | 193.15M |
| October 04, 2024 | 248.63M |
| October 03, 2024 | 273.47M |
| October 02, 2024 | 310.55M |
| October 01, 2024 | 331.68M |
| September 30, 2024 | 371.16M |
| Date | Value |
|---|---|
| September 27, 2024 | 360.11M |
| September 26, 2024 | 377.93M |
| September 25, 2024 | 382.67M |
| September 24, 2024 | 377.41M |
| September 23, 2024 | 372.33M |
| September 20, 2024 | 364.20M |
| September 19, 2024 | 315.42M |
| September 18, 2024 | 363.23M |
| September 17, 2024 | 354.71M |
| September 16, 2024 | 351.59M |
| September 13, 2024 | 483.03M |
| September 12, 2024 | 235.49M |
| September 11, 2024 | 126.16M |
| September 10, 2024 | 93.19M |
| September 09, 2024 | 76.34M |
| September 06, 2024 | 26.00M |
| September 05, 2024 | 25.35M |
| September 04, 2024 | 29.19M |
| September 03, 2024 | 23.92M |
| August 30, 2024 | 24.05M |
| August 29, 2024 | 14.91M |
| August 28, 2024 | 15.59M |
| August 27, 2024 | 17.03M |
| August 26, 2024 | 19.37M |
| August 23, 2024 | 21.45M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-177.97M
Minimum
Dec 27 2022
3.228B
Maximum
Mar 26 2021
556.39M
Average
60.72M
Median
Nov 09 2022
Enterprise Value Benchmarks
| Merck & Co Inc | 284.75B |
| Elite Pharmaceuticals Inc | 534.85M |
| BioCardia Inc | 3.655M |
| Zevra Therapeutics Inc | 451.06M |
| PetIQ Inc | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.92M |
| Total Expenses (Quarterly) | 13.63M |
| EPS Diluted (Quarterly) | -2.29 |
| Earnings Yield | -66.18% |